CONTENTS
Issue 72 | July 2018
Will rapid reform open the world’s second biggest drug market?
What regulatory steps need to be taken to improve US adoption of biosimilars?
How can TriNetXdata boost clinical research efforts?
A new method of manufacturing proteins is unlocking new possibilities
How close are we to a drug-based solution to opioid addiction?
A new drug combination could treat hepatitis C for a fraction of the cost
How does BenevolentAI plan to change the way we discover new drugs?
Are poor animal research studies compromising human health?
Future pricing strategies for gene and cell therapies
Life sciences firms need to adapt how they approach data management
The industry is undergoing dramatic change as new tech brings disruption